MicroRNAs in the Host Response to Viral Infections of Veterinary Importance by Mohamed Samir et al.
October 2016 | Volume 3 | Article 861
Review
published: 17 October 2016
doi: 10.3389/fvets.2016.00086
Frontiers in Veterinary Science | www.frontiersin.org
Edited by: 
Dirk Werling, 
Royal Veterinary College, UK
Reviewed by: 
Kieran G. Meade, 
Teagasc – The Irish Agriculture and 
Food Development Authority, Ireland 
Frederick Joseph Fuller, 
North Carolina State University, USA 
Troels Scheel, 
University of Copenhagen, Denmark
*Correspondence:
Frank Pessler  
frank.pessler@twincore.de
†Present address: 
Lea A. I. Vaas, 
Fraunhofer IME ScreeningPort, 
Hamburg, Germany
Specialty section: 
This article was submitted to 
Veterinary Infectious Diseases, 
a section of the journal 
Frontiers in Veterinary Science
Received: 01 June 2016
Accepted: 12 September 2016
Published: 17 October 2016
Citation: 
Samir M, Vaas LAI and Pessler F 
(2016) MicroRNAs in the Host 
Response to Viral Infections of 
Veterinary Importance. 
Front. Vet. Sci. 3:86. 
doi: 10.3389/fvets.2016.00086
MicroRNAs in the Host Response  
to viral infections of veterinary 
importance
Mohamed Samir1,2, Lea A. I. Vaas1† and Frank Pessler1,3*
1 TWINCORE, Center for Experimental and Clinical Infection Research, Hannover, Germany, 2 Department of Zoonoses, 
Faculty of Veterinary Medicine, Zagazig University, Zagazig, Egypt, 3 Helmholtz Center for Infection Research, 
Braunschweig, Germany
The discovery of small regulatory non-coding RNAs has been an exciting advance in the 
field of genomics. MicroRNAs (miRNAs) are endogenous RNA molecules, approximately 
22 nucleotides in length, that regulate gene expression, mostly at the posttranscrip-
tional level. MiRNA profiling technologies have made it possible to identify and quantify 
novel miRNAs and to study their regulation and potential roles in disease pathogenesis. 
Although miRNAs have been extensively investigated in viral infections of humans, their 
implications in viral diseases affecting animals of veterinary importance are much less 
understood. The number of annotated miRNAs in different animal species is growing 
continuously, and novel roles in regulating host–pathogen interactions are being discov-
ered, for instance, miRNA-mediated augmentation of viral transcription and replication. 
In this review, we present an overview of synthesis and function of miRNAs and an 
update on the current state of research on host-encoded miRNAs in the genesis of viral 
infectious diseases in their natural animal host as well as in selected in vivo and in vitro 
laboratory models.
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iNTRODUCTiON AND BRieF HiSTORY
The recent discovery of non-coding RNAs, such as long non-coding RNAs (lncRNAs) and micro-
RNAs (miRNAs), has begun to direct more and more attention to these potentially very powerful 
regulatory molecules. The first miRNA was discovered in 1993 during studies of the timing of 
embryonic development of different larval stages of the worm Caenorhabditis elegans (C. elegans). 
In this experiment, Lee and colleagues observed that the RNA transcribed from the lin-4 locus did 
not encode a protein but instead silenced the gene encoding Lin-14, an important protein in larval 
Abbreviations: 3′-UTR, 3′-untranslated region; ALV, avian leucosis virus; BIC, B-cell integration cluster; BSE, bovine 
spongiform encephalopathy; CJD, Creutzfeldt–Jakob disease; CNS, central nervous system; DGCR8, DiGeorge syndrome 
critical region 8; DIANA, DNA intelligent analysis; GaHV-2, Gallid herpesvirus 2; HPAI, highly pathogenic avian influenza; 
IBDV, infectious bursal disease virus; IAV, influenza A virus; lncRNAs, long non-coding RNAs; MDV, Marek’s disease virus; 
miRNAs, microRNAs; NLRP3, NOD-like receptor P3; nts, nucleotides; PRRSV, porcine reproductive and respiratory syndrome 
virus; pre-miRNA, precursor miRNA; pri-miRNA, primary miRNA; RISC, RNA-induced silencing complex; RNA seq, RNA 
sequencing; RT-qPCR, reverse transcription quantitative real-time PCR; RV, rabies virus; REV-T, reticuloendotheliosis virus 
strain T; SDN, small RNA degrading nucleases; snoRNA, small nucleolar RNA; SOCS, suppressor of cytokine signaling; TGEV, 
transmissible gastroenteritis virus; TRBP, TAR RNA binding protein; VEEV, Venezuelan equine encephalitis virus; VCJD, 
variant Creutzfeldt–Jakob disease.
FiGURe 1 | The classic endogenous miRNA pathway and mechanisms of action. In the nucleus, pri-miRNA is transcribed by RNA polymerase II and further 
processed by the Drosha enzyme to produce pre-miRNA, which is then transported into the cytoplasm. There it is cleaved by the Dicer enzyme into the miRNA 
duplex. The guide strand is uploaded onto the RNA-induced silencing complex (RISC) to regulate gene expression by causing either target mRNA degradation or 
translation repression. Cytoplasmic-nuclear shuttle is possible for some miRNAs (e.g., miR-29b, miR-320, and miR-373). Adapted from Wikimedia Commons 
(“Difference DNA RNA-EN.SVG”).
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development (1). Since then, the number of studies on miRNAs 
has been rising rapidly. Indeed, a PubMed search (August 4, 
2016; keyword “microRNA”) revealed an increase from 5 entries 
in 2001 (the first year this term appeared) to 10,189 entries in 
2015. MiRNA-encoding genes comprise only 1–5% of the animal 
genome but have been estimated to affect approximately 30% of 
all protein-coding genes (2, 3). It is being recognized that their 
regulatory roles are much more sophisticated than initially 
thought, owing to the cooperativity (i.e., more than one miRNA 
species can target the same mRNA) and the multiplicity of their 
targets (i.e., one miRNA can target hundreds of mRNA species) 
(4). miRNAs have been shown to play important roles in essen-
tially all biological processes (5), and the differential expression 
of host miRNAs during infection (1, 6) supports the idea that 
they may constitute key players in the host response to invad-
ing pathogens. We recently summarized trials of therapeutic 
interventions based on small non-coding RNAs for treatment or 
prevention of infectious diseases of veterinary importance (7). 
The current review presents an update on miRNA biogenesis and 
profiling, discusses some of the challenges encountered when 
studying them in animals, and summarizes current knowledge of 
the roles of miRNAs in viral infectious diseases in their respective 
natural animal hosts. In addition to this, information obtained 
from cellular and laboratory animal models is presented in cases 
where data from natural infection are not available or are difficult 
to obtain. Furthermore, we include some examples of important 
animal viral diseases where in vitro studies have revealed roles for 
miRNAs. We also discuss miRNA involvement in prion diseases 
as examples of fatal, untreatable diseases caused by infectious 
proteins. Viruses, particularly DNA viruses [Marek’s disease virus 
(MDV), bovine herpesvirus] and even retroviruses (e.g., bovine 
leukemia virus), can also encode their own miRNAs, but due to 
space limitations, this topic is not emphasized in this review, and 
we refer the reader to excellent existing reviews [e.g., Ref. (8, 9)].
MicroRNA BiOGeNeSiS PATHwAY  
AND MeCHANiSMS OF ACTiON
MicroRNAs are non-coding single-stranded oligoribonucleo-
tides of about 22 nucleotides (nts) in length. Their biogenesis 
and mode of action is illustrated in Figure 1, but the reader is 
3Samir et al. miRNAs in Veterinary Viral Infections
Frontiers in Veterinary Science | www.frontiersin.org October 2016 | Volume 3 | Article 86
also referred to excellent recent reviews of miRNA biogenesis, 
e.g., Ref. (10). miRNAs can be transcribed from within protein-
coding genes (intragenic miRNAs), from dedicated miRNA 
coding genes (intergenic miRNAs), or from genes encoding 
other ncRNA classes, such as small nucleolar RNA (snoRNA) 
and lncRNAs. More than half of vertebrate miRNA genes lie 
in introns, implying that most miRNAs are co-expressed with 
specific host mRNAs (11, 12), although specific transcription 
start sites for miRNA coding sequences also exist (13). While 
the majority of miRNA genes are physically separated on the 
genome (14, 15), many functionally related miRNA genes often, 
but not always, reside in clusters within the genome (16), prob-
ably because they are processed from the same polycistronic 
transcript (6). When they have their own promoter, miRNA 
genes are transcribed mainly by RNA polymerase II and, rarely, 
by RNA polymerase III (17) to form primary miRNAs (pri-miR-
NAs) (18), which are then folded to produce hairpin structures. 
Each hairpin structure consists of a 32-nt-long imperfect stem 
and a large terminal loop. The enzyme Drosha and its cofactor 
DiGeorge syndrome critical region 8 (DGCR8) cleave the 22 nts 
downstream of the stem to yield 60-nt-long precursor miRNAs 
(pre-miRNA) (18). The pre-miRNAs are then exported to the 
cytoplasm via exportin 5 where the terminal loops are excised 
by Dicer and tar RNA binding protein (TRBP) to produce short 
imperfect miRNA duplex intermediates (19). This duplex is then 
unwound by a helicase into two miRNA strands. One strand (the 
5′-strand or guide strand for most miRNAs) is incorporated into 
the RNA-induced silencing complex (RISC) to target mRNAs, 
and the other strand (3′-strand, also referred to as miRNA*) 
is usually degraded but can also persist and take on regulatory 
roles of its own.
Apart from the classic biogenesis pathway, Dicer or AGO-2-
independent (non-canonical) pathways have also been described 
(20). For instance, mirtrons are miRNAs that are produced from 
introns by the splicing machinery instead of the Drosha process-
ing complex (21). The maturation of some miRNAs (for example, 
miR-451) is Dicer independent, but AGO dependent. This is pos-
sibly because the stem part of its pre-miRNA is too short (17 bp) 
to be processed by Dicer (22).
MicroRNAs mainly act in the cytoplasm, namely, by repress-
ing mRNA translation and, to a lesser extent, by inducing mRNA 
degradation. Actually, the two processes can be connected in 
that decreased translation may lead to loss of stability. Usually, 
the seed region (seven or eight consecutive nts at the miRNA 5′-
end) binds to complementary sequences in the 3′-untranslated 
region (UTR) of the target mRNA (23), but miRNAs can also 
target other sequences, such as the 5′-UTR or coding sequences 
(24). Remarkably, some miRNAs have been implicated in actu-
ally stimulating translation (25, 26). miRNAs can also affect gene 
expression at the level of pre-mRNA splicing. Usually, this occurs 
indirectly in that a miRNA regulates translation of a protein 
involved in differential splicing. miR-124 represents a good 
example of this: during neuronal differentiation of the mouse, it 
binds to the mRNA encoding a repressor of alternative splicing, 
PTBP1, leading to increased synthesis of the PTBP2 protein. The 
latter, in turn, induces alternative splicing programs leading to 
neuronal differentiation (27).
Interestingly, mature miRNAs can also be found in the 
nucleus (28–30). Profiling studies of fractionated cells revealed 
the enrichment of miRNAs, including miR-320, miR-373, and 
miR-29b, in the nucleus of cell lines derived from various origins 
(28, 29, 31–34). The driving force of this cytoplasmic-nuclear 
shuttle, at least for miR-29b, is thought to be a miRNA-associated 
hexanucleotide terminal motif (AGUGUU) which increases the 
stability of the miRNA (29). Their localization in the nucleus 
suggests that these nuclear miRNAs affect gene expression at 
critical steps that take place in the nucleus, notably transcrip-
tion. One mechanism by which they can affect transcription is 
to promote gene silencing by inducing epigenetic changes, such 
as histone modifications or methylation of promoter elements 
(35, 36). Remarkably, it has been shown that a nuclear miRNA 
can even stimulate transcription by binding to a complementary 
promoter sequence (34). Taken together, these studies suggest 
that the scope of miRNA functions has become broader than 
previously thought. miRNAs themselves can be regulated by sev-
eral mechanisms. In general, miRNA half-life ranges from hours 
to days, but this obviously varies depending on the organ, body 
fluid, and cell type (37). Compared to other RNA species, their 
stability in stored biosamples is generally much higher than that 
of other RNA species, which increases their value for biomarker 
studies using biobanked animal or human biosamples (7). For 
instance, in contrast to mRNA, they are highly stable in formalin-
fixed paraffin-embedded tissue blocks, allowing for localization 
and expression studies even after years of storage (38). Active 
degradation can be mediated by small RNA degrading nucleases 
(SDNs) [reviewed in Ref. (39)]. miRNAs can also be extruded 
from the cell into body fluids (e.g., blood, CSF, urine) in exosomes 
or microvesicles. On one hand, this may be an additional mecha-
nism by which intracellular miRNA populations can be regulated. 
On the other hand, these vesicles can also function as vehicles by 
which miRNA can spread systemically and potentially be taken 
up by accessible cells (40, 41). More recently, it was found that 
miRNA activity can be inhibited by sequestration by circular 
RNAs (“miRNA sponges”) (42).
UPDATe ON iDeNTiFiCATiON OF miRNAs 
AND COMPUTATiONAL PReDiCTiON OF 
THeiR TARGeTS iN ANiMALS OF 
veTeRiNARY iMPORTANCe
In vertebrates, miRNAs have been studied most extensively in 
humans and mice, in part because much fewer miRNAs have 
been annotated or made publicly available in other organisms, 
including animals of veterinary importance (43). Figure 2 shows 
the number of currently annotated mature and immature miR-
NAs in different animal species of veterinary importance, as well 
as in humans and mice, according to miRBase version 21 (43). 
Humans and mice had the highest number of annotated miR-
NAs, followed by chicken, cattle, and horse. miRNA expression 
profiling has assisted in identifying miRNAs that regulate a range 
of biological processes, and there are several established and 
emerging methods for measuring miRNA expression profiles 
in biological samples. The commonly used approaches include 
FiGURe 2 | Numbers of currently annotated mature and immature miRNAs in selected species. The most recent numbers of immature (black bars) and 
mature (gray bars) miRNAs in animals of veterinary importance are plotted on the y-axis. Values for humans and mice are shown for comparison. Data were 
obtained from miRBase version 21.
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reverse transcription quantitative real-time PCR (RT-qPCR), 
microarrays, and RNA sequencing (RNA seq) (44, 45). In the 
process of discovering novel miRNAs, the analysis of profiling 
data follows the same principle in that the generated reads have 
to be mapped to the reference genome of the concerned species. 
In this context, the lack of a published reference genome always 
represents a limitation. The unique feature of cross-species con-
servation of miRNAs has aided in the identification of miRNAs 
or their targets especially in the species where the genome (or 
the miRNome) is not completely annotated (46). The miRNAs 
from such species have been identified by homology searches 
where the deep sequencing reads are aligned against the genome 
of the most closely related species (47). Indeed, most bovine 
miRNAs have been identified in this way, and a similar method 
was used to identify goat and sheep miRNAs (48). Researchers 
from China recently characterized miRNA species in skin and 
ovaries of ducks (49, 50). An alternative strategy was used in 
these studies. First, the reads were filtered and then mapped by 
blast alignment to all known mature chicken miRNA sequences 
present in miRBase. The sequences that did not correspond to 
chicken miRNAs were then mapped to miRNAs in other species. 
This strategy has also been applied to the Chinese hamster (51). 
There are several computational resources for the identification 
of miRNAs and their targets (52). Among these, miReader is a 
newly launched bioinformatics tool for the discovery of novel 
miRNAs that can be used to identify miRNAs that are not anno-
tated in miRBase, yet without the need for reference genomic 
sequences or homologous genomes. It shows a high degree of 
accuracy in a wide range of animal species (47). The prediction 
and validation of miRNA targets are essential steps in deter-
mining their regulatory function. In this regard, the imperfect 
complementarity between the miRNAs and their mRNA targets 
represents a major challenge because of potentially false positive 
predictions. Nevertheless, various online target prediction tools 
have been developed. Prominent tools include TargetScan (53), 
miRanda (54), PITA (55), and RNA hybrid (56). Most of these 
tools rely on basic principles, such as miRNA/mRNA pairing, 
cross-species conservation of the mRNA 3′-UTR, and the free 
energy required to form the duplex (57, 58). Kiriakidou indi-
cated that the agreement of mRNA targets predicted for a set 
of 79 miRNAs by several target prediction tools was only in the 
range of 10–50% (59). One reason for this may be the divergent 
use of the degree of conservation. For example, conservation 
may be used but not directly incorporated into the score (as in 
PITA), or not used at all (as in RNA22) (60). It is worth men-
tioning that these tools exhibit some differences, which might 
be independent of the algorithms, such as using different UTR 
databases for prediction, cross-species comparison, or align-
ment artifacts. Other among-tools variations that are related 
to the prediction algorithms themselves include the number 
of nts involved in pairing (canonical, marginal, and atypical 
seed-matched sites) (61), the method used to measure 3′-UTR 
conservation, the accessibility to the UTR, and the statistical 
approach used (62). The computational approaches for predict-
ing miRNA–mRNA binding revealed wide variation and bias. 
Therefore, various experimental strategies have been developed 
in humans, for instance, “Cross-linking and sequencing of 
hybrids” (63), which allow the identification of miRNA–target 
pair chimeras in deep sequencing data (64). Some attempts 
have been successful to use the mRNA targets to predict 
biological pathways that are regulated by a set of miRNAs. 
For instance, the DNA intelligent analysis (DIANA) tool (65) 
offers the miRPath server, which can create hierarchical clusters 
of miRNAs and pathways based on the levels of the predicted 
miRNA/mRNA interactions. Generally, a major limitation of the 
available web tools is that they include a limited number of species 
5Samir et al. miRNAs in Veterinary Viral Infections
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(e.g., human, mouse, C. elegans), leaving many animal species 
underrepresented, in particular those of veterinary importance. 
However, some tools (e.g., TargetScan, miRDP, and Microcosm) 
include some species of veterinary importance, such as chicken, 
dog, and cow (3, 66, 67). Oasis is a comprehensive online tool 
for the analysis of RNAseq data that allows for target prediction 
and analysis of novel (putative) miRNAs, including prediction 
of miRNomes of species without annotated miRNomes (68). 
The growing list of annotated miRNAs in species of veterinary 
importance undoubtedly warrants better inclusion of such 
species in the online prediction algorithms. Considering the 
probability of obtaining false positive and negative results using 
the online prediction algorithms, it seems critical to confirm 
miRNA function using experimental work. The function of a 
miRNA can be validated by several experimental approaches. 
The luciferase reporter assay can be used to test for binding of a 
miRNA to a predicted target sequence (69). To detect the effect 
of miRNA–mRNA pairing on the protein level, immunoblotting 
can be employed. For a detailed analysis of procedures used for 
the experimental validation of miRNA targets, we recommend 
references (70–72). In situ hybridization using a labeled anti-
sense probe can be used to investigate which cell type in a tissue 
expresses a certain miRNA (73), but this is technically not easy, 
for instance, because an endogenous counterpart miRNA that 
also contains the antisense sequence may compete with binding 
of the probe to the target miRNA.
MicroRNAs iN THe HOST ReSPONSe  
TO viRAL iNFeCTiONS OF veTeRiNARY 
iMPORTANCe
Considering the implication of miRNAs in nearly all biological 
processes, links between miRNAs and disease status are expected. 
Earlier reports suggested that miRNAs are involved in the regu-
lation of inflammatory pathways as well as adaptive and innate 
immunity, stress factors, and cytokine signaling (74). Diseased 
tissues may show unique miRNA expression patterns, which 
subsequently might affect virus replication and/or survival. For 
instance, miRNAs might promote virus replication by direct 
pairing with virus-derived transcripts, as has been shown for 
miR-122 and hepatitis C virus (75). A similar mechanism is 
utilized by bovine viral diarrhea and classic swine fever viruses, 
where miR-17 and let-7 were found to bind their 3′UTRs, thus 
enhancing stability and translation of viral mRNA (76). miRNAs 
may restrict viral replication, as exemplified by miR-32 in primate 
foamy virus type 1 infection (77).
When studying regulation of host- or virus-encoded RNA 
targets by miRNAs, the “abundance problem” needs to be con-
sidered. Based on studies in cell lines, it has been argued that 
approximately 100 copies of a miRNA are needed to affect host 
transcripts and, depending on the number and activity of viral 
genomes in the cell, likely a higher number to affect viral tran-
scripts (78). Thus, expression changes of low copy number miR-
NAs during infection may be of little functional consequences. 
Studies on regulation of host miRNAs in infection often ignore 
this potentially important issue.
Studies of changes in miRNA populations in infections in the 
natural host are clearly limited by the fact that they usually do not 
allow to distinguish between cause and effect (and therefore do 
not allow to draw conclusions as to mechanisms) but are mostly 
suitable for biomarker studies and for formulating hypotheses 
based on the descriptive data obtained. These can then be tested 
in the appropriate experimental models, if available. Another 
point to be considered is that a good part of the host miRNome 
response to infection may be due to collateral cell and tissue dam-
age and turnover and not due to the immune response per  se. 
Clearly, our understanding of the mechanistic associations and 
implications of miRNAs in animal viral infectious diseases is still 
far from complete. Here, we review the literature that describes 
the expression of miRNAs in the context of viral infectious dis-
eases that affect farm and pet animals, with special emphasis on 
infections in the natural host. Additionally, we discuss miRNA 
expression in infectious viral diseases in laboratory in vivo and 
in vitro models where there are no sufficient data involving the 
natural host.
infections in the Natural Host
Influenza A Virus
Infection with influenza A virus (IAV) has a negative impact 
on the poultry and swine industries, and on human health in 
that it is able to cross species barriers and adapt to the human 
host. The differences in pathogenesis of various IAV strains are 
attributed to both viral and host factors. Yet, there remains an 
urgent need for diagnostic markers to sense the very early phases 
of IAV outbreaks at the farm level. The first trial to emphasize the 
effect of miRNAs on IAV pathogenesis in a species of veterinary 
importance attempted to define miRNA populations in lung and 
trachea of commercial Leghorn chickens experimentally infected 
with H5N3 virus (79) (Table 1). Some miRNAs were upregulated 
in both lung and trachea, and others showed a tissue-specific 
pattern. For instance, miRNA-206 was more highly expressed 
in infected than in non-infected lungs, while the reverse was 
reported for trachea. These findings suggest that specific host 
miRNA regulatory mechanisms might exist in response to IAV 
infection (79). The same research group subsequently confirmed 
that host cellular miRNAs following H5N3 virus challenge 
could lead to different results depending on the host genetic 
background (80). They proved that host-encoded miRNAs were 
modulated differentially in the lungs of broiler and layer chickens 
(Table S1 in Supplementary Material). In broilers, more miRNAs 
were upregulated than downregulated, whereas this was reversed 
in layers. Only two miRNAs, miR-1599 and miR-1416, were 
consistently regulated independent of chicken breed. Since this 
study showed a breed-dependent effect on miRNA expression, 
the authors proposed that miRNA expression is linked to immu-
nity. Some of the identified miRNAs have predicted target sites 
in immune-related genes, such as IL17RD, ARL11, CHMP2B, 
POU1F1, PDHB, and HIF1AN. Indeed, broiler chickens have 
weak short-term humoral immunity, whereas layers possess a 
long-term humoral immune response and strong cellular immu-
nity, which goes in line with the fact that layers have a longer 
life expectancy (81). Regarding immunity-related miRNAs, Li 
and his colleagues claimed that miRNAs account for part of the 
TABLe 1 | Selected studies reporting differentially expressed host-encoded miRNAs in animal viral infectious diseases of veterinary importance (in vivo 
studies of natural infection and laboratory models).
Disease 
reservoir
Disease or 
pathogen
miRNAs Function(s) Tissue Reference
Upregulated Downregulated
Horse Venezuelan equine 
encephalitis virus 
(VEEV)
Various (n = 24)a Various (n = 43) Cell death, apoptosis, and 
inflammation
Brain (92)
Layer 
chickens
Influenza A virus 
(H5N3)
miR-1a, miR-140, miR-449 miR-181a Regulation of host and viral gene 
expression
Lung and 
trachea
(79)
Layer 
chickens
Influenza A virus 
(H5N3)
miR-445, miR-34b, miR-34c, miR-1a-1, 
miR-1a-2, miR-1b, miR-449, miR-140
miR-181a Regulation of host and viral gene 
expression
Trachea (79)
Broiler 
chickens
Influenza A virus 
(H5N3)
Various (n = 25)a miR-449b, miR-460a, 
miR-206, miR-301, and 
miR-187
Regulation of host and viral gene 
expression
Lung (80)
Dog and 
carnivore
Rabies miR-1894-5p, miR-290-3p, miR-1901, 
miR-207, miR-1896, miR-715, miR-
3470b, miR-146ba, miR-203, miR-770-5p
miR-200a, miR-200b,  
miR-200c, miR-182,  
miR-183, and miR-429
Targeting RIG-1 like receptor, RIF3 
(a target for miR-203), and TRIM25 
(a target of miR-207)
Brain (93)
Pig Influenza A virus 
(H1N2)
miR-21, miR-15a, miR-206, miR-451, 
miR-223
miR-146 Inflammation Lung (83)
Cattle, 
sheep, goat, 
cat
Prion protein-
related diseases
miR-342-3p, miR-320, let-7b, miR-328, 
miR-128, miR-139-5p, miR-146a
miR-338-3p and 
miR-337-3p
Regulation of pro-inflammatory 
cytokine production
Brain (94, 95)
The column “Tissue” refers to the tissue in which the respective profiling study was conducted. Expression in human tissues is reported in Ref. (96). The column “Function” refers to 
the function of all miRNAs contained in the corresponding column. Due to space limitations, several other studies are contained in Table S1 in Supplementary Material.
aA complete list of all miRNAs is provided in Table S1 in Supplementary Material.
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immune-related differences between chickens and ducks upon 
H5N1 infection. They showed that, in contrast to duck, the 
dynamics of the miRNA repertoires of chicken spleen, thymus, 
and bursa changed upon infection, with more miRNAs being 
upregulated than downregulated (Table S1 in Supplementary 
Material). A set of spleen-specific miRNAs were found to target 
genes in the B-cell receptor pathway (82). This study potentially 
explains the differential susceptibility to IAV infection between 
chickens and ducks based on miRNA expression differences. In 
pig, miRNAs were found to be dysregulated in the lungs after 
aerosol challenge with reassortant IAV (H1N2). Some miRNAs 
were upregulated 1, 3, and 14  days after infection (miR-15a); 
others were expressed late (miR-21, miR-206, and miR-451) or 
transiently upregulated (miR-223), whereas miR-146 was tran-
siently downregulated (Table  1). These miRNAs target several 
inflammation-related molecules (83). In a recent experiment that 
also involved pig, Jiang et al. showed that miRNAs of piglet pul-
monary alveolar macrophages differed in expression during acute 
(4 days post infection) and recovery (7 days post infection) phases 
of IAV (H1N1) infection. By day 4, most of the miRNAs (n = 70) 
were downregulated, presumably allowing an increase in their 
target mRNAs that participate in the host defense against viruses. 
Three days later, the expression levels of most miRNAs returned 
to normal, with subsequent normal expression of immune genes 
during the recovery phase (Table S1 in Supplementary Material) 
(84). The isolation of H3N8 in 2005 from infected dogs in the 
United States, and the identification of H3N2 in 2007 from dogs 
in Korea and China marked the emergence of canine influenza 
virus (85, 86). In 2014, Zhao et al. conducted an experiment in 
which they profiled the miRNA expression patterns in lung and 
trachea of beagles experimentally infected with H3N2 virus (87). 
In this study, 34 and 45 miRNAs were differentially expressed 
between infected and non-infected groups in lung and trachea, 
respectively (Table S1 in Supplementary Material). In addition, 
99 miRNAs were differentially expressed between infected lung 
and trachea. Interestingly, miRNA expression levels were higher 
in infected than in non-infected lungs, the reverse was reported 
in trachea, indicating a tissue-specific signature of miRNAs and 
suggesting that these miRNAs may play different roles in differ-
ent organs. The divergence in the results obtained from various 
studies might be due to different strains or models used. Other 
publications have documented miRNA involvement in the host 
response to IAV infection in animals and humans, but using 
cell-based models (88–91). Considered together, these studies 
suggest that a specific host miRNA response is associated with 
IAV infection and could contribute to the pathogenesis of IAV 
including its tissue/cell tropism and host preference.
Influenza A Virus Infection as an Example of Cross-Species 
Conservation of Host-Encoded miRNAs
All IAV subtypes primarily originated in wild birds that are clas-
sified under the orders Anseriformes and Charadriiformes (97). 
Their migration and aquatic nature enable both the maintenance 
of IAV strains as well as the emergence of novel strains in spillover 
hosts. While mice can be infected with IAV only after serial pas-
sages (98), domestic chicken, swine, and humans are among the 
main transmission reservoirs (99). Species-dependent variation 
in the host response to IAV has been reported, including in 
chickens and ducks (100). Despite their potential roles in inter-
species differences in host responses to infections, a global view 
FiGURe 3 | miRNAs that are regulated in iAv infection in humans, chicken, pig, and mice. (A) Venn diagram depicting miRNAs that are differentially and 
commonly expressed in the four species. (B) Heat map showing the pathways regulated by two of the three miRNAs regulated in all four species. (C) Sequence 
alignment of the premature form of miR-223, a well characterized miRNA that is regulated in all four species. While the mature form of this miRNA is highly 
conserved across the four species (represented by stars above the sequences), the premature form shows a lesser degree of conservation. The seed region is 
highlighted in gray.
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of cross-species expression, conservation, and functionality of 
miRNAs is incomplete and spread across several studies. In order 
to obtain an overview of shared and distinct miRNAs in an infec-
tious disease that affects both animals of veterinary importance 
and humans, we compiled the literature on miRNAs regulated 
upon IAV infection in humans (91, 101, 102), mice (103–108), 
chicken (79, 80, 82), and pig (83, 84), extracted all miRNAs (sepa-
rately for each species) that have been shown to be differentially 
regulated upon IAV infection (Table S2 in Supplementary 
Material), and selected those miRNAs that are regulated in all 
four species. Naturally, this analysis needs to be interpreted 
knowing that its negative predictive value is low due to publica-
tion bias and differences in the numbers of studies done in the 
various hosts; on the other hand, the positive predictive value 
likely is high. As shown in Figure 3A, three miRNAs (miR-18a-5p, 
miR-223-3p, and miR-451-3p) were differentially regulated in all 
four species, suggesting a common IAV infection-related signa-
ture. Limiting the analysis to the three natural hosts (humans, 
chicken, and pig) revealed an additional three consistently 
 regulated miRNAs (miR-18b-3p, miR-22-5p and miR-30a-3p). 
The expression patterns and tissue specificities of these miRNAs 
are listed in Table  1 and Table S1 in Supplementary Material. 
These six miRNAs are related to diverse biological processes. The 
role of miR-223 in infection, inflammation, and cancer has been 
reviewed extensively (109). An association between miR-223 and 
IAV virulence has been proposed in several studies. Among these, 
Li et al. observed an upregulation of miR-223 in mice infected 
with the lethal r1918 pandemic H1N1, but not the less virulent 
Tx/91 strain. The authors also reported that miR-223 can indi-
rectly repress the transcription factor CREB, which is responsible 
for maintaining cell survival and growth (110), suggesting that 
the lethal IAVs may induce cellular apoptosis via increasing 
expression of miR-223 (103). Using a luciferase-based reporter 
assay, Haneklaus et  al. showed that overexpression of miR-223 
tends to reduce luciferase expression in the vector containing the 
3′-UTR of NOD-like receptor P3 (NLRP3), implying that miR-
223 can target NLRP3 with subsequent reduction in activity of the 
NLRP3-inflammasome (111). In another study, miR-223 was 
shown to be upregulated in lung of mice experimentally infected 
with two IAV (H5N2) strains of differential virulence. The more 
virulent strain induced miR-223 more strongly than the less viru-
lent strain, and subsequent administration of anti-miR-223 to 
these mice reduced IAV titer and increased animal survival and 
weight gain at 1, 3, and 5 days after inoculation, suggesting a posi-
tive correlation between miR-223 levels and severity of IAV 
infection in this model (112). IAV infection leads to changes in 
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expression of miR-155 in humans, chickens and mice, but in pigs, 
interestingly, only of its counterpart miR-155-3p. MiR-155 has 
been found to regulate both innate and adaptive arms of the 
immune system. On the one hand, CD8+ T cells transduced with 
the MigR1 vector overexpressing miR-155 showed a higher 
expansion and proliferation rate compared to the negative con-
trols, suggesting a role for this miRNA in the T cell response 
(113). On the other hand, overexpressing and blocking miR-155 
in a murine macrophage cell line indicated that miR-155 can 
target the suppressor of cytokine signaling (SOCS), a negative 
regulator of IFN-α, thereby triggering the antiviral type 1 IFN 
response (114). In support of this, Choi et  al. found that mice 
injected with anti-miR-155-3p displayed a dramatic loss in body 
weight and succumbed to IAV infection within 8 dpi with high 
viral titers in their lungs (112). These studies suggest that IAV may 
usurp host miRNAs for its own benefits. The pathogenesis of IAV 
involves effector molecules that converge to form interacting 
signaling pathways (115). To test the hypothesis that there are 
common miRNA-regulated functional pathways that are induced 
upon IAV infection, we utilized the bioinformatics tool DIANA 
miRPath v.2.0 (65) to predict pathways that might be regulated by 
these miRNAs. For this purpose, we chose the smaller set of 
miRNAs regulated also in the mouse (an adaptive, well-studied 
host for IAV) and the murine functions of the DIANA tool, as it 
does not support analyses of chicken and pig miRNAs, and also 
because the mouse is the one of the four species with the best 
experimental evidence for miRNA function at the organismal 
level. Figure 3B shows the pathways regulated by two of these 
three miRNAs, i.e., miR-18a-5p and miR-223-3p (miR-451-3p is 
not included in the DIANA tool). Among the identified pathways, 
endocytosis and the PI3K–Akt, MAP kinase, mTOR, and TGF-β 
signaling pathways are known to be associated with IAV–host 
interaction. The PI3K pathway is mainly involved in apoptosis. 
Binding of the NS1 gene of IAV to the P85β regulatory subunit 
activates PI3K, leading to phosphorylation of the downstream 
effector molecule Akt, which further phosphorylates both caspase 
9 and GSK-3β, thereby suppressing apoptosis and prolonging 
virus infection (116). Hirata et al. suggested that inhibiting Akt 
kinase activity may have therapeutic advantages for IAV infection 
by interfering with viral entry and replication (117). Besides the 
PI3K pathway, MAP kinases have been reported to promote IAV 
ribonucleoprotein capsid trafficking and virus production (118) 
and to regulate the production of RANTES, a chemokine that is 
released by lung epithelial cells and alveolar macrophages (119). 
Among the identified pathways, the TGF-β signaling pathway is 
known to be activated by the IAV neuraminidase. The authors 
claimed that the modulation of TGF-β activity during IAV infec-
tion influences viral titers and disease outcome in experimentally 
infected mice, suggesting a significant role for TGF-β signaling in 
IAV pathogenesis. Interestingly, this study postulated that the 
inability of H5N1 virus to trigger the TGF-β cascade might 
explain the improper host immune response and the exaggerated 
immune pathology seen in many H5N1 cases (120). Clathrin-
mediated endocytosis is a prerequisite for IAV entrance into target 
cells (121). For further descriptions of the implication of the 
predicted IAV-associated pathways, we recommend references 
(115, 122). The remaining 12 pathways are mainly related to 
cancer, but we cannot rule out any possible roles for these path-
ways in IAV infection, as cancer-related pathways are often also 
involved in the host response to infection. To gain further insight 
into the cross-species conservation of functionally related miR-
NAs, we then used the ClustalX version 2.0 software (123) to align 
the sequences of the stem-loop (premature) form of miR-223 in 
humans, mice, chicken, and pig (Figure 3C). The degree of con-
servation was higher in the mature miRNA than in the rest of the 
stem-loop sequence. In terms of sequence identity, the mature 
form of miR-223 was more closely related to the corresponding 
sequences in mice than in chicken and pig. The seed region was 
100% identical among the four species studied. Shared seed 
sequences might indicate shared miRNA targets, lending further 
support to the notion that these miRNAs play similar roles in 
these species in the host response to IAV infection. Additional 
functional implications of these shared miRNAs in the course of 
IAV infection are discussed in Ref. (7).
Infectious Bursal Disease Virus
Infectious bursal disease virus (IBDV) is the etiologic agent of 
infectious bursal disease, which is a highly contagious disease 
that predominantly affects the bursa of Fabricius in birds (124). 
Although vaccination has contributed to the overall reduction 
of disease burden in poultry (125), several challenges remain 
to be overcome, and new approaches are needed to fight IBDV 
(126). The initial study that indicated an anti-IBDV effect of 
miRNAs in its natural host was conducted in 2011 (127). In this 
experiment, the authors reported that transducing 8-day-old SPF 
chicken embryos with an adeno-associated virus vector carrying 
VP1- and VP2-specific miRNAs resulted in reduced replication 
of the Lukert strain of IBDV by 48 hpi. In a subsequent study, gga-
miR-9* was found to be induced 2, 4, 12, and 24 h after infection 
with IBDV (128). The authors also provided evidence that miR-9* 
can promote IBDV replication by repressing the production of 
IFN. These data indicate that miRNAs can either stimulate or 
inhibit BDV infection and that their roles as therapeutic interven-
tions merit further investigations.
Marek’s Disease Virus
Marek’s disease is a highly contagious viral neoplastic disease 
of chicken that results from infection with Gallid herpesvirus 2 
(GaHV-2), also known as MDV (129). The disease has remained 
a major concern in poultry owing to the continual emergence of 
new virulent strains (130). Although several in vitro approaches 
have been employed to unravel the roles played by host-encoded 
miRNAs in different scenarios of MDV infection (131–136), 
fewer studies have addressed their role in the natural host. 
Initially, deep sequencing of samples from MDV-infected chicken 
spleen and liver revealed that 187 miRNAs were differential 
expressed compared to the non-infected tissues. These miRNAs 
were found to target genes that are related to lymphomagenesis 
(134) (Table S1 in Supplementary Material). Stik et  al. (137) 
used white leghorn chicken experimentally inoculated with the 
oncogenic RB-1B strain as a model to investigate connections 
between the chicken miRNA response and the oncogenic nature 
of MDV. This study reported that gga-miR-21 was upregulated 
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in chicken inoculated with the oncogenic strain, as compared to 
chicken vaccinated with the non-oncogenic strain CVI988 and 
non-infected chicken. gga-miR-21 was also found to promote 
tumor formation by targeting the chicken programmed cell death 
4 (PDCD4) mRNA. In the same context, miR-103 was found to 
be downregulated in tumor samples from spleen and liver of 
infected chickens, where it targets cyclin E1 and the transcription 
factor Dp-2, which normally causes suppression of cell migration 
and tumor formation (138). Similarly, miR-26a was found to be 
downregulated in MDV-infected chicken spleens during different 
phases of tumor formation (139). This miRNA targets the “Never 
In Mitosis Gene A-related kinase 6” gene, which was strongly 
upregulated in the same samples (suggesting loss of inhibition due 
to miR-26a) and has been linked to cell proliferation. Collectively, 
these in vivo studies emphasized the role of host miRNAs in the 
development of MDV-associated tumors in chickens. In terms 
of susceptibility to infection, Tian et  al. identified 64 miRNAs 
(58 downregulated and 6 upregulated) that were differentially 
expressed between MDV-infected and non-infected chicken cells 
when the susceptible line 72 was used, but not when the resistant 
cell line 63 was used (140). The differentially expressed miRNAs 
were found to target components of several immune-related 
pathways, such as NF-κB signaling and T-cell and B-cell receptor 
signaling, raising the possibility that miRNAs might influence 
the genetic susceptibility of chicken to MDV infection through 
controlling immune responses.
Avian Leukosis Virus
Avian leukosis virus (ALV) belongs to the genus Alpharetrovirus 
of the Retroviridae family. This virus is capable of inducing 
tumors in avian hosts, including B-cell lymphoma, hemangioma, 
and myelocytoma (141). As discussed above in MDV infection, 
miRNAs have proven to be strongly associated with virus-induced 
avian tumors through regulating cell proliferation or cell death 
(141, 142). Among the first studies on miRNA-mediated control 
of ALV-J infection is the one conducted by Li et al. in 2012. They 
investigated miRNA expression in the liver of ALV-J-infected 
10-week-old chickens. They proposed that seven upregulated miR-
NAs (gga-mir-221, gga-mir-222, gga-mir-1456, gga-mir-1704, 
gga-mir-1777, gga-mir-1790, and gga-mir-2127) might play a 
tumorigenic role, whereas downregulation of five other miRNAs 
(gga-let-7b, gga-let-7i, gga-mir-125b, gga-mir-375, and gga-
mir-458) was associated with loss of tumor suppressive functions 
(143). In agreement with this, gga-miR-375 was found to be 
downregulated in the liver of ALV-J-infected chicken compared 
to non-infected animals. Overexpression of this miRNA led to a 
significant inhibition in the proliferative capacity of DF-1 chicken 
fibroblasts, likely via targeting and repressing yes-associated 
protein 1, cyclin E, and Drosophila inhibitor of apoptosis protein 
1 mRNAs (144). Conversely, increased replication of ALV-J 
was associated with the upregulation of miR-23 in the spleen of 
ALV-J-infected chickens. This miRNA can target and suppress 
interferon regulatory factor 1, thus allowing enhanced virus 
replication (145). Similarly, Dai et  al. found that miR-221 and 
miR-222, which were upregulated in the liver of ALV-J-infected 
chickens, can act as tumorigenic agents by targeting BCL-2 
modifying factor (146). In another study, microarray analysis 
of liver tumors from ALV-J-infected chicken indicated that gga-
miR-221, gga-miR-193a, gga-miR-193b, and gga-miR-125b were 
differentially expressed. Gene ontology and pathway analyses of 
these miRNAs indicated that ALV-J-triggered tumorigenesis may 
be, at least in part, due to these miRNAs targeting the MAPK and 
Wnt signaling pathways (147). Collectively, these data indicate 
that miRNAs form an integral part of the host response to ALV-J 
infection and can influence its pathogenesis by promoting or 
repressing tumor formation. They also suggest that modulating 
miRNA expression does have potential for interventional strate-
gies against ALV-J infection.
infections in Laboratory Animal Models
Venezuelan Equine Encephalitis Virus
Venezuelan equine encephalitis virus (VEEV) is an equine dis-
ease that can be transmitted to humans via a mosquito vector 
and cause lethal inflammation of brain tissue. Mortality rates 
in equines have been estimated at 19–83% but are below 1% in 
humans (148). Reports suggest that miRNA expression is highly 
regulated upon VEEV infection of neurons and glial cells. Bhomia 
et al. (92) were the first to describe miRNA expression patterns 
in a mouse model of VEEV infection. Twenty-five miRNAs were 
upregulated, and 4 were downregulated in brain tissue collected 
after 48 and 72 h (Table S1 in Supplementary Material). Mmu-
miR-155 showed >5-fold higher expression at both time points, 
suggesting that it might serve as an indicator of VEEV infection. 
These miRNAs may play important roles in modulating gene 
expression and neuronal degeneration in the brain following 
VEEV infection.
Rabies Virus
Rabies virus (RV) is a neurotropic virus that can infect the central 
nervous system (CNS) and lead to death in many cases of human 
infection. Canines constitute the main reservoir, but nearly all 
warm-blooded animals can contract the infection. The disease is 
transmissible from dogs to humans. Every year, it causes 55,000 
human deaths worldwide (149). Thus, controlling the disease in 
domestic dogs has important implications for public health. In 
mice challenged with RV, a strong modulation in the expression of 
miRNA molecules was observed (Table 1), and the differentially 
expressed miRNAs are thought to be involved in several immune-
associated signaling pathways (93). In another study, miR-133, 
which is specifically expressed in skeletal muscle, was predicted 
to bind to both N and G transcripts of RV (150). This might be a 
plausible explanation for the lengthy dormant state of this virus in 
skeletal muscle during the early phase of infection and before the 
continuation of its journey through the nervous system.
Prion Protein-Related Diseases
Prion proteins are the causative agents of bovine spongiform 
encephalopathy (BSE; “mad cow disease”) in cattle, feline 
spongiform encephalopathy in cats, scrapie in sheep, and 
Creutzfeldt–Jakob disease (CJD) in humans. This group of fatal 
neurodegenerative disorders is caused by an abnormally folded 
form of the naturally occurring cellular prion precursor protein, 
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PrPc. Over the last 15 years, intense efforts have been undertaken 
following the appearance of a new prion disease that is trans-
missible to humans, variant Creutzfeldt–Jakob disease (VKJD). 
Ingestion of meat from BSE-infected cattle or scrapie-infected 
sheep is the source of infection (151). There is compelling 
evidence of a role played by miRNAs in the pathogenesis of the 
prion-related diseases. Brain of mice infected with mouse-adapted 
scrapie showed a unique expression pattern of 15 miRNAs that 
might act during prion-induced neurodegeneration. Most of them 
were upregulated more than 2.5-fold (Table  1). Among these, 
only miR-128 had previously been shown to be dysregulated in 
other neurodegenerative diseases, suggesting a pattern specific 
for these closely related diseases (94, 95). To determine whether 
miRNA dysfunction is involved in prion disease pathogenesis, the 
authors used a BSE-infected cynomolgus macaque model to con-
firm that miR-342-3p was upregulated in brain (152). Moreover, 
the authors confirmed that hsa-miR-342-3p was upregulated in 
brain samples of human type 1 and type 2 sporadic CJD, sug-
gesting that miR-342-3p may be a biomarker of prionopathies 
in animals and humans. This also indicates that this miRNA 
might affect pathogenesis in different species. In another study, 
Taganov et al. proposed a role for miR-146a as a potent modulator 
of microglial function by controlling the activation state during 
prion-induced neurodegeneration (153). In general, miR-146a 
can directly downregulate the production of pro-inflammatory 
cytokines by acting as a negative-feedback effector of the NF-κB 
pathway (154). A coordinated dysregulation of miRNAs seen in 
prion diseases may be a response to the abnormal accumulation 
of PrPSc, leading to signaling pathways that induce alterations in 
neurotransmitter receptors and protein degradation, resulting in 
the ultimate failure of neuronal function.
infections in Cellular Models
In addition to the above mentioned in vivo models, there are sev-
eral examples of in vitro trials that have unraveled multiple roles of 
cellular miRNAs in different scenarios of infections with animal 
viral diseases of veterinary importance. One prominent example 
can be seen in the oncogenic miR-155 (155). miR-155 was initially 
identified as a gene that was activated by promoter insertion at a 
common retroviral integration locus in B-cell lymphomas called 
B-cell integration cluster (BIC) (156). B-cell lymphomas express 
greater levels of miR-155 and BIC transcripts than normal B cells 
as both of them are processed from the same primary transcript 
(157). By generating bic/miR-155-deficient mice, Rodriguez 
et al. provided evidence that absence of BIC/miR-155 resulted in 
lung fibrosis mimicking the picture of complicated autoimmune 
diseases, reduced amount of immunoglobulin M, and low levels 
of IL-2 and IFN-γ, suggesting a key role for miR-155 in regulating 
immune responses (158). Extensive studies have been performed 
thereafter to illustrate miR-155 roles in tumor viruses affecting 
animals. One example is the reticuloendotheliosis virus strain T 
(REV-T). Infection of chicken embryo fibroblasts and REV-T-
induced B-cell lymphomas demonstrated elevated miR-155 levels 
(159). Further functional studies revealed that miR-155 can target 
JARID2 mRNA (a cell cycle regulator) causing its downregula-
tion, reflecting the role of miR-155 in promoting cell survival. 
Using a comparable in vitro approach, miR-181a was linked to 
MDV-induced lymphoma. In this regard, transfecting miR-181a 
mimic into MYBL1 cells, a Marek’s disease lymphoma cell line, 
resulted in the reduction of v-myb myeloblastosis viral oncogene 
homolog-like 1 protein. The study also showed an inhibitory 
effect of gga-miR-181a on cell proliferation (160). A similar role 
was reported for miR-26a in MDV infection, where it inhibited 
lymphoma cell proliferation by targeting NEK6, thus playing 
a role as a tumor suppressor (133). Transfection of a lentiviral 
vector expressing miR-21 into DF-1 cells has been demonstrated 
to inhibit IBDV replication via targeting the VP1 gene of this 
virus (161). Using a luciferase reporter assay, Wang et al. proved 
that chicken miR-1650 can bind the 5′-UTR of the ALV-J Gag 
mRNA, therefore influencing virus replication (162). In bovine 
medicine, bovine viral diarrhea is a significant disease of cattle, 
which is still endemic in many parts of the world (163). The role 
of miRNA in bovine viral diarrhea infection has been illuminated 
in two recent studies. In the first, the authors reported that miR-
29b can bind to the 3′-UTR of two key apoptosis-related genes, 
caspase-7 and nuclear apoptosis-inducing factor 1, causing their 
downregulation in Madin–Darby bovine kidney (MDBK) cells. 
They also showed that miR-29b could target the viral envelope 
glycoprotein with subsequent suppression of viral replication 
(164). In the second study, the same researchers proved that 
lentivirus-mediated overexpression of the miR-29b precursor 
reduced replication of bovine viral diarrhea virus in MDBK cells 
by downregulating the expression of ATG14 and ATG9A, two 
important autophagy-associated proteins (165). These studies 
emphasize that miR-29b can modulate the pathogenesis of bovine 
viral diarrhea virus using different mechanisms. Along the same 
lines, PK-15 cells were used to screen for differentially expressed 
miRNAs during foot-and-mouth disease virus (FMDV) infection 
(166). The analysis revealed that 172 known miRNAs and 72 puta-
tive miRNAs were differentially expressed, the majority of which 
were downregulated. Bioinformatics analyses predicted that the 
target mRNA genes of these differentially expressed miRNAs were 
involved in pathways such as cytokine receptor signaling, NOD-
like receptor signaling, and toll-like receptor signaling. Another 
example from the swine field can be seen in porcine reproductive 
and respiratory syndrome virus (PRRSV) infection, which is a 
main cause of late abortion and respiratory diseases in pigs (167). 
Several in vitro trials were performed to understand the role of 
miRNAs in the pathogenesis of PRRSV infection. Recently, it was 
found that PRRSV infection triggered miR-24-3p expression that 
downregulated heme oxygenase-1 mRNA, which was associated 
with an overall increase in PRRSV replication in the MARC-145 
cell line (168). Other reports demonstrated the ability of some 
miRNAs to restrict PRRSV replication. For instance, miR-26a acts 
by enhancing type I IFN-signaling pathways and augmenting the 
production of IFN-stimulated genes, thus blocking virus replica-
tion (169). A virus inhibitory effect is mediated also by miR-506, 
which suppresses the mRNA encoding CD151, an important 
receptor of PRRSV (170). In the MARC-145 cell line and primary 
porcine alveolar macrophages, PRRSV induced downregulation 
of miR-125b as a way to enhance its replication. This miRNA 
was found to block the NF-κB pathway, which is essential for 
PRRSV replication (171). Profiling studies of PRRSV-infected 
porcine alveolar macrophages revealed altered expression of 40 
FiGURe 4 | Schematic representation of infectious viral diseases of farm and pet animals (in natural hosts and in laboratory models) where miRNAs 
have been reported to play a role. Examples of these diseases are bovine spongiform encephalopathy (BSE); feline spongiform encephalopathy (FSE); rabies; 
influenza A virus (IAV); infectious bursal disease virus (IBDV); Marek’s disease virus (MDV); avian leukosis virus (ALV); scrapie; and Venezuelan equine encephalitis 
(VEE). Adapted from Ref. (182).
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miRNAs, including miR-30a-3p, miR-132, miR-27b*, miR-29b, 
miR-146a, and miR-9-2, of which miR-147 could be shown to 
inhibit virus replication (172). Swine testis cells infected with 
transmissible gastroenteritis virus (TGEV) uniquely expressed 
59 miRNAs (15 upregulated and 44 downregulated). The 
authors argued that these miRNAs are involved in targeting host 
signaling pathways, including metabolic and immune-related 
pathways (173). A  similar profiling study in TGEV-infected 
PK-15 cells demonstrated that increased expression of miR-4331 
can suppress the transcription of TGEV gene 7 via targeting 
cellular cell division cycle-associated protein 7 (174). Recently, 
overexpression and silencing studies revealed that miR-27b is an 
important suppressor of apoptosis triggered by TGEV, possibly by 
targeting the runt-related transcription factor 1 gene. The authors 
concluded that the virus can induce apoptosis by downregulat-
ing this miRNA in the infected cells (175). Targeting elements 
of a viral genome is an intriguing way by which miRNAs may 
interfere with viral infections. For instance, miR-181c was found 
to bind a highly conserved region in the PRRSV genome, causing 
specific and dose-dependent reduction in virus titers in Marc-145 
cells, implicating miR-181c in a pathogen-specific host response 
to PRRSV infection and supporting the idea of using miRNAs 
in the control of PRRSV infection (176). Similar inhibitory 
mechanisms (targeting MDV in this case) have been reported for 
miR-23, miR-378, and miR-505 (133). Eastern equine encephalitis 
virus (EEEV) constitutes another example where a host miRNA 
modulates viral activity. miR-142-3p inhibits EEEV replication in 
myeloid cells by binding to its 3′-UTR, which leads to a reduced 
immune response accompanied by exacerbated disease manifes-
tations in the CNS. An intriguing opposite effect is seen in the 
mosquito vector in that miR-142-3p binding sites in the 3′-UTR 
are required for efficient viral replication, which would augment 
transmission to the mammalian hosts (177).
Taken together, the results of the studies presented in this 
section provide additional evidence for the importance of host 
miRNAs in the pathogenesis of viral infectious diseases of 
animals and provide encouraging preliminary data for the use 
of small non-coding RNAs targeting viral genomes as antiviral 
interventional strategies.
PeRSPeCTiveS
Many miRNAs have been identified that may affect pathogenesis 
and outcome of viral infectious diseases of veterinary impor-
tance. Nevertheless, many open questions remain. Inter-host 
differences in susceptibility to a given viral infection are often 
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due to differences in mRNA and, subsequently, protein expres-
sion, and the intriguing role of miRNAs in regulating these 
differences certainly requires further investigations. In this 
regard, we propose that the study of highly pathogenic avian 
influenza (HPAI) infections in different avian and mammalian 
hosts would constitute a promising model system of high rel-
evance to veterinary practice. While infection is asymptomatic 
in waterfowl, humans and chicken are more susceptible and 
develop a concurrent strong inflammatory response and high 
tissue cytokine levels (178). Also, pathogenicity of HPAI H5N1 
viruses varies among various breeds of ducks (179). In the 
same context and as a deviation from the normal ecology of 
the virus, some recent isolates of H5N1 proved to be lethal for 
waterfowl species, including ducks (180). Given these observa-
tions, comparing the expression patterns of host-encoded 
miRNAs in response to HPAI in different hosts, organs, and 
disease states might explain their difference in susceptibility to 
HPAI infection and help to identify additional elements of the 
host response that affect disease severity. One research area of 
great scientific interest and of clinical importance as well is to 
investigate the role of miRNAs in the development of viral and 
bacterial coinfections, such as IAV/S. pneumoniae in humans 
and IAV/Escherichia coli in chicken and ducks (181), as the role 
of host miRNAs in modulating potential synergies between two 
pathogens may be substantial. Human populations experienced 
the emergence of zoonotic diseases, in particular those caused 
by viruses that cause varying numbers of human fatalities. It is 
important to invest more efforts to delineate the role of miRNAs 
that are associated with these zoonotic viral diseases, especially 
when considering their cross-species conservation. This will 
improve our understanding of the complex nature of zoonotic 
pathogens as well as their potential to further establish interhu-
man transmission.
CONCLUSiON
The discovery of small non-coding RNAs was a turning point in 
biology. The role of miRNAs has grown with an unprecedented 
speed from research on worms to a wide variety of physiologi-
cal and pathological processes in humans and animals. With 
genome-wide profiling techniques and the tools of bioinformat-
ics, considerable information about miRNAs and their role in 
animal viral diseases is now available. The current experimental 
data on the role of miRNAs in host–virus interaction upon 
infection of a natural host, in laboratory models and in cell-
based systems, indicate that miRNAs can contribute to both 
pathogenesis and clinical outcome of many diseases affecting 
animal populations on the individual and farm level (Figure 4). 
However, a general conclusion on the role of miRNAs cannot be 
drawn yet. One possibility is that they favor the host as part of the 
antiviral response. This could occur in two ways. First, miRNAs 
could silence viral transcripts through sequence-specific bind-
ing, and thus protein expression. Second, they could indirectly 
modulate host transcripts in a way that creates a less favorable 
condition for virus propagation and survival. Vice versa, host 
miRNAs may be beneficial for the viral pathogens if they tend 
to increase their replication or survival. Finally, they can be 
beneficial for both sides as in the case of latent viruses. The role 
of miRNAs in veterinary medicine is receiving more and more 
attention. Considering the current efforts to include more hosts 
of veterinary importance in online miRNA databases, as well the 
increased availability of high-throughput profiling approaches 
and functional studies, our understanding of the roles of 
miRNAs in viral infections of veterinary importance will likely 
continue to improve and lead to tangible clinical applications in 
the foreseeable future.
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